It is through the innovation authority Vinnova that the company NorthXBiologics receives a grant of approximately 50 million.
The company recently bought the factory in Matfors from Cobra Biologics and now the government hopes that the so-called innovation hub, which the company has been commissioned to create, will enable the production of advanced drugs and vaccines.
- If an RNA vaccine were needed for a new pandemic, we could in the future produce more than what Sweden needs and probably more than what the Nordic countries need, says NorthXBiologics' CEO Ted Fjällman.